Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Translational Medicine

Topics

Biology

Bioinformatics

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1186/s12967-024-05339-9

License

CC-BY

Other Formats

PDF